Skip to main content
Back to articles
Portfolio manager moveConfirmed 23 May 2023

Torbjørn Bjerke left the Arctic Aurora LifeScience management team

Torbjørn Bjerke stepped away from the day-to-day management of Arctic Aurora LifeScience on 25 May 2023, when he became chief executive of Swedish biotechnology company SynAct Pharma. Bjerke had served as a partner and portfolio manager at Arctic Asset Management and was involved in establishing Arctic Aurora LifeScience. He nevertheless retained a connection to the strategy as chairman of the advisory board for Arctic Aurora LifeScience and Arctic Aurora Biotech Select. The departure therefore represented a change within the investment team rather than a complete management transition. Ulrica Slåne Bjerke remained responsible for the strategy alongside Daniel Bolanowski.
Share this article

Related